
Researchers investigated the incidence of moderate to severe side effects for patients being treated with a combination of TKI and immunotherapy.

Researchers investigated the incidence of moderate to severe side effects for patients being treated with a combination of TKI and immunotherapy.

If you have lymphedema after breast cancer and want to enjoy the company of cats, there are strategies to avoid potential problems, especially scratches.

Afinitor did not improve relapse-free survival in patients with non-clear cell renal cell carcinoma — a kidney cancer subtype linked to poor prognosis.

Chemotherapy-related baldness pressured my strained self-identity. Was I the same person?

In August 2024, the FDA approved six new cancer treatments, including some that haven’t previously been approved.

In preparation for a family member’s wedding, I purchased a new bra and protheses and felt like a princess by doing so.

Patients with cancer who did 20-minute guided mindful breathing tended to have a more significant decrease in cancer-related pain and anxiety.

I wrote this letter to cancer because my brother died too early.

The FDA will speed up their review of Enhertu for HR-positive, HER2-low/ultralow advanced breast cancer that cannot be removed via surgery.

Cancer has changed my self-image, but I’ve learned a few tricks to help boost my self-confidence.

Even when I didn’t feel like riding, brushing and grooming her kept my spirits up and provided a social outlet that wasn’t medically oriented.

The Food and Drug Administration approved frontline Lazcluze plus Rybrevant for locally advanced or metastatic non-small cell lung cancer with an EGFR exon 19 deletions or exon 21 L858R substitution mutations.

I could tell from the way the staff and patients spoke of her that she was special, and I quickly saw for myself, too.

After being cancer-free for five years, I struggle with my own existence. However, I find meaning in helping others through their cancer experience.

The first FDA-approved systemic therapy may be beneficial to patients with low-grade astrocytoma or oligodendroglioma with IDH1 or 2 mutations.

As I visit the cancer center for chemotherapy to treat my CLL, I can’t help but take note of how different cancer may look in each person.

Cancer-related fatigue guidelines from 2024 explained which interventions help manage the side effect and explain why certain medications may not be helpful.

Not only Julie Kirby, RN, OCN, make a recovery, but she has returned to nursing and manages our chemotherapy department.

My wife and children were by my side as I underwent grueling and life-changing prostate cancer treatment.

Cancer gave me a new “fluffy” perspective on life.

From Susan Wojcicki and Rachael Lillis dying of cancer to the President Biden announcing that Cancer Moonshot initiative received $150 million, here’s what’s happening in the oncology space.

Patients with NSCLC who are overweight or obese should discuss chemotherapy versus immunotherapy for frontline treatment, research showed.

Imfinzi has been approved as a presurgical treatment with platinum-based chemotherapy and postsurgical treatment alone in surgically removable NSCLC.

Researchers have identified genetic differences that can make leukemia relapse more or less likely among pediatric patients.

Treatment with postoperative radiotherapy for early breast cancer was beneficial within the first decade, but then the risk of recurrence may increase.

My views on scars — both physical and emotional — changed throughout my cancer experience.

Patients with NSCLC taking five or more medications tended to have worse survival, highlighting the need for medication management, research showed.

The Food and Drug Administration will fast-track the development of AC699 for patients with ER-positive, HER2-negative ESR1-mutant advanced or metastatic breast cancer.

Researchers compared health-related quality of life among patients ages 60 and older with acute myeloid leukemia undergoing different chemotherapy regimens.

Niktimvo was approved for adults and children with chronic, pretreated graft-versus-host disease.